Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Ribociclib bulk supplier for pharma manufacturers

Ribociclib 200 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 200 mg

Reference Brands: Kisqali (USA/EU)

Category: Oncology Cancer Care

Ribociclib is a cyclin‑dependent kinase (CDK 4/6) inhibitor. It works by blocking CDK 4 and CDK 6, proteins that help cancer cells grow and divide, thereby reducing or slowing the growth of certain breast cancer cells. Ribociclib is used together with hormonal therapies, such as aromatase inhibitors or fulvestrant, in hormone receptor‑positive (HR+), HER2‑negative breast cancer, whether early (high‑risk) or advanced/metastatic.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Ribociclib — third party manufacturing & bulk supply

Ribociclib 200 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Ribociclib is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Ribociclib listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Ribociclib →
Back to Listing

Frequently Asked Questions

Ribociclib is used to treat hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced or metastatic breast cancer, typically in combination with endocrine therapy. It works by inhibiting cyclin-dependent kinases 4 and 6 (CDK4/6), which slows cancer cell growth.

Ribociclib is made from the active pharmaceutical ingredient ribociclib succinate, a selective CDK4/6 inhibitor.

The trade name is Kisqali.

Kisqali is manufactured by Novartis.

The generic name is ribociclib succinate.

The primary brand name is Kisqali.

It is manufactured in approved facilities in Europe, the USA, and other regions depending on regulatory approvals.

Related Products

Ziftomenib

Strength:
200 mg

Form: Capsules

Reference Brands: Komzifti (USA)

View Details
Adagrasib

Strength:
200 mg

Form: Tablets

Reference Brands: Krazati (USA)

View Details
Dostarlimab-Gxly

Strength:
500 mg

Form: Injection

Reference Brands: Jemperli(USA/EU)

View Details
Mitomycin Pyelocalyceal

Strength:
40 mg

Form: Injection

Reference Brands: Jelmyto (USA/EU)

View Details
Flutamide

Strength:
125mg, 250mg

Form: Tablets / Capsules

Reference Brands: Eulexin (USA/EU), Cytomid (EU)

View Details
Pazopanib

Strength:
200mg, 400mg

Form: Tablets

Reference Brands: Votrient

View Details
Decitabine

Strength:
5mg/ml

Form: Injection

Reference Brands: Dacogen (USA)

View Details
Triptorelin

Strength:
3.75 mg, 11.25 mg, 22.5 mg,

Form: Injection

Reference Brands: Trelstar (USA), Triptodur (USA), Gonapeptyl (EU / UK)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.